Loading...
01/10 22:41
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals strong financial performance with a 13% increase in revenue and a 15% rise in ACV plus royalties, reflecting growing demand. Record high revenue and strategic wins with major clients like AMD are positive indicators. While there are some concerns about expenses, the optimistic guidance for revenue and cash flow, alongside strategic partnerships and product developments, suggests a positive outlook. However, the lack of clarity on certain metrics in the Q&A slightly tempers enthusiasm, but the overall sentiment remains positive, likely leading to a stock price increase of 2% to 8%.
Total Revenue $16.5 million, up 13% year-over-year. The increase was driven by strong deal execution and growing demand for system IP technology.
Annual Contract Value (ACV) plus Royalties $69.1 million, up 15% year-over-year. This growth reflects increased adoption of Arteris' technology, particularly in enterprise computing and automotive applications.
Remaining Performance Obligations (RPO) $99.3 million, representing a 28% year-over-year increase. This highlights the growing demand for Arteris' system IP technology.
Non-GAAP Gross Profit $15 million, representing a gross margin of 91%. This was driven by efficient cost management and strong revenue growth.
GAAP Gross Profit $14.8 million, representing a gross margin of 89%. This aligns closely with the non-GAAP gross profit, reflecting consistent financial performance.
Non-GAAP Operating Expense $18.6 million, 10% higher year-over-year. The increase was due to scaling investments in R&D and field application engineering teams.
GAAP Operating Expense $23 million, representing a 12% year-over-year increase. This was driven by strategic investments in new product development and customer support.
Non-GAAP Operating Loss $3.5 million, flat year-over-year. This reflects controlled spending and efficient operations.
GAAP Operating Loss $8.2 million, compared to a loss of $7.4 million in the prior year period. The increase was influenced by higher operating expenses.
Non-GAAP Net Loss $4.4 million or $0.11 per share. This was in line with guidance and reflects ongoing investments in growth initiatives.
GAAP Net Loss $9.1 million or $0.22 per share. This was higher than the prior year due to increased operating expenses.
Free Cash Flow Negative $2.8 million. This was approximately at the midpoint of guidance and reflects capital expenditures and operational investments.
FlexGen adoption: AMD, a global leader in high-performance computing, signed an agreement to utilize Arteris FlexGen technology for AI applications. Over two dozen FlexGen installations are now operational, and the product is expected to contribute to revenue over time.
Magillem Packaging: A new software product designed to automate IP packaging, simplifying and speeding up the process of assembling silicon chiplets and chips. It aims to reduce errors and delays in integrating IP blocks.
AI-driven market expansion: Increased adoption of Arteris technology in enterprise computing and automotive applications, driven by AI computing needs. Strategic wins include AMD and Whalechip, a fabless semiconductor provider.
Multi-die solution expansion: Expanded support for Universal Chiplet Interconnect Express (UCIe), Arm AMBA protocols, and collaborations with Synopsys, Cadence, and RISC-V ecosystem partners. This supports the shift towards multi-die or chiplet architectures in AI applications.
Revenue growth: Total revenue for Q2 2025 was $16.5 million, up 13% year-over-year.
Record performance metrics: Annual contract value plus royalties reached $69.1 million, a 15% year-over-year increase. Remaining performance obligations were $99.3 million, up 28% year-over-year.
Customer outsourcing trend: Major customers are increasingly outsourcing system IP needs to Arteris to accelerate time-to-market, reduce costs, and improve operational efficiencies.
Global Economic Uncertainty: The company is monitoring global economic uncertainty, which could potentially impact deal cancellations or delays in the future, even though it did not affect the second quarter.
Foreign Exchange Fluctuations: The weakening U.S. dollar, especially against the euro, has increased operating expenses and could continue to impact financial performance if exchange rates remain unfavorable.
Rising Operating Expenses: Operating expenses have increased due to scaling investments in R&D, customer support, and sales expansion, which could pressure profitability if revenue growth does not keep pace.
Complexity of Multi-Die SoCs: The increasing complexity of multi-die SoCs and the need for reliable integration of numerous IP blocks could lead to costly errors and delays if not managed effectively.
Dependence on Key Customers: The company’s growth is tied to relationships with major customers like AMD and Renesas. Any disruption in these relationships could adversely affect revenue.
Third Quarter 2025 Guidance: ACV plus royalties expected to range from $69.5 million to $72.5 million. Revenue projected between $16.8 million and $17.2 million. Non-GAAP operating loss anticipated to be between $3 million and $4 million. Non-GAAP free cash flow expected to range from $0.5 million to $3.5 million.
Full Year 2025 Guidance: ACV plus royalties projected to exit 2025 at $72 million to $78 million. Revenue expected to range from $66 million to $70 million. Non-GAAP operating loss forecasted between $10.5 million and $15.5 million. Non-GAAP free cash flow anticipated to range from $1 million to $7 million.
Foreign Exchange Impact: Operating expenses are higher than expected due to the weakening U.S. dollar, particularly against the euro. Guidance assumes current foreign exchange rates remain stable for the rest of 2025.
Customer Trends and Outsourcing: Promising signs of increased interest from major customers to outsource system IP products to Arteris, potentially accelerating product time-to-market and improving operational efficiencies.
The selected topic was not discussed during the call.
The earnings call summary shows strong financial performance with significant revenue growth, high gross margins, and positive free cash flow. The Q&A highlights opportunities with major companies like AMD and Altera, and the focus on AI and data centers is promising. The management's avoidance of booking details is a minor concern, but overall, the optimistic guidance, strong partnerships, and strategic investments suggest a positive outlook for the stock price.
The earnings call reveals strong financial performance with a 13% increase in revenue and a 15% rise in ACV plus royalties, reflecting growing demand. Record high revenue and strategic wins with major clients like AMD are positive indicators. While there are some concerns about expenses, the optimistic guidance for revenue and cash flow, alongside strategic partnerships and product developments, suggests a positive outlook. However, the lack of clarity on certain metrics in the Q&A slightly tempers enthusiasm, but the overall sentiment remains positive, likely leading to a stock price increase of 2% to 8%.
The earnings call presents mixed signals: record high revenue and strong ACV growth are positive, but operational losses and increased expenses due to currency fluctuations are concerning. Management's optimistic guidance is tempered by geopolitical risks and trade uncertainties. The Q&A reveals steady licensing activity and potential growth in FlexGen, but no acceleration in decision timelines. The lack of guidance on book-to-bill ratio is a red flag. Given these factors, a neutral stock price movement is likely, as positives are balanced by risks and uncertainties.
The earnings call shows strong financial performance with record high revenues and significant annual contract value plus royalties. Despite operational losses, improvements were noted, and guidance remains optimistic. The Q&A section highlighted strong product adoption and positive ASP trends. However, management's lack of clarity on specific bookings figures slightly tempers enthusiasm. Overall, the positive financial metrics and guidance suggest a likely stock price increase in the short term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
